Module 1


This module will provide the participants with an overview of lymphoma/CLL, the pathophysiology and subtype classifications and an overview of the current management of lymphoma.

The session will also provide an insight into the patient experience and will provide participants with the opportunity to reflect on what the lymphoma/CLL patient may experience after a diagnosis of this cancer .

At the completion of module one participants will understand:

  • The pathophysiology of lymphoma and CLL
  • How lymphoma develops
  • How lymphoma is classified
  • The difference between Hodgkin and non-Hodgkin lymphoma
  • The difference between indolent and aggressive non-Hodgkin lymphoma
  • Overview of the management of lymphoma
  • The patient experience and how nurses can influence this
  • Issues that are of concern to people with lymphoma and their loved ones

Module one presentations

Part 1: Lymphoma/CLL pathophysiology & subtype classification
Doctor Jason Butler

Senior Staff Haematologist & vice-chair Lymphoma Australia; Royal Brisbane & Women’s Hospital & Sunshine Coast University Hospital

Dr Jason Butler is a clinical haematologist with Icon Cancer Centre, and a Senior Staff Haematologist at the Royal Brisbane and Women’s Hospital. Dr Butler completed his dual training in clinical and laboratory haematology in 2004 following a research posting at the Queensland Institute of Medical Research investigating the role of bcl-2 in primary resistance in chronic myeloid leukaemia. He also completed a master’s in medical science (Clinical Epidemiology) to assist with development of investigator-initiator research studies.

His major clinical interests are in all aspects of malignant haematology, particularly in myeloma and lymphoma, as well as autologous and allogeneic stem cell transplantation. He is the Tumour Stream Lead for myeloma at the Royal Brisbane and Women’s Hospital, acting as a principal investigator in a number of clinical trials including CAR-T therapy and other novel approaches to management of lymphoma.

Dr Butler is the current chair of the Haematology Reference Committee of eviQ, the Australian-based governance committee establishing consensus guidelines for cancer treatments, and a council member of the Australian and New Zealand Society of Blood and Marrow Transplantation.

Part 2: The Patient’s Experience
Donna Gairns – National Nurse Manager Lymphoma Australia

National Nurse Manager, Lymphoma Australia

Donna has over 25 years of experience as a Registered Nurse, specialising in Haematology and Oncology nursing after gaining her degree at Victoria University of Technology in 1995. Starting her career at St Vincent’s Hospital Oncology/Haematology unit in Melbourne, she then worked for 2 years at St Bartholomew’s Hospital, London. Donna then worked at the Peter MacCallum Cancer Centre for over 17 years in a variety of clinical settings giving her experience in many treatment modalities including, Haematology and Autologous Stem Cell Transplantation; Chemotherapy Day Unit (Associate Nurse Manager, Specialist Nurse Coordinator & Nurse Educator); Adolescent & Young Adult (AYA) Nurse Consultant within the Victorian & Tasmanian AYA Cancer Service at Peter Mac.

Donna is passionate about improving the patient experience through support, advocacy and education. She is also dedicated to enhancing the knowledge of cancer nurses caring for the lymphoma patients through education and support.

  • eviQ Haematology, Lymphoma and CLL Reference Committee Member
  • Victorian Nurse, Haematology Society of Australia & NZ (HSANZ) committee Member
  • National AYA Nurse Committee member – Cancer Nurse Society of Australia

Post assessment

To be eligible for a certificate of attendance, you need to complete a short assessment. The certificate will be emailed to you shortly after you have submitted the assessment.

Evaluation Survey

Please complete our short evaluation survey (if you haven’t done so already) to let us know if we met your expectations and ensure we meet your future learning needs.

Further reading and resources

The 2016 revision of the World Health Organization classification of lymphoid neoplasms

Lymphoma Coalition

Support and information

Share This

Newsletter Sign Up

Contact Lymphoma Australia Today!